Anatibant
| CAS No. | 209733-45-9 | Cat. No. | BCP18839 |
| Name | Anatibant | ||
| Synonyms | LF 16-0687; LF-16-0687; LF16-0687; LF 160687; LF-160687; LF160687; | ||
| Formula | C34H36Cl2N6O5S | M. Wt | 711.66 |
| Description | Anatibant, also known as LF 16-0687, is a potent non-peptide bradykinin B2 receptor antagonist. Anatibant reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury. The inhibition of bradykinin B2 receptors seems to be a promising treatment option for traumatic brain injury. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Bradykinin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.